FindTrial
Sign In

Bone health in Very Preterm babies after optimal nutrient supplementation

Metabolic Bone Disease in Preterm Neonates on optimal phosphorous supplementation â?? a prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/12/029576
Enrollment
62
Registered
2020-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all preterm babies who are less than or equal to 30 weeks of gestational age

Exclusion criteria

Exclusion criteria: 1.Antenatally diagnosed Renal diseases resulting in abnormal renal function 2.Acquired renal Failure 3.Severe surgical gastrointestinal anomalies / disease.

Design outcomes

Primary

MeasureTime frame
Incidence of Metabolic Bone disease among preterm neonates on optimal phosphorous supplementationTimepoint: 4 weeks of post natal life to 48weeks of completed gestational age—

Secondary

MeasureTime frame
1.Hyperkalemia 2.Hyperphosphatemia 3.Ventilation days (as a measure of bone health) 4.Days to full feeds (as a measure of feed intolerance, due to early use of HMF) 5.Effect on linear growth â?? length and OFC at 48 weeks PMA Timepoint: During NICU stay till 48 weeks of completed gestational age—

Countries

India

Contacts

Public ContactDr Naveen Jain

Kerala Institute Of Medical Sciences

naveen_19572@hotmail.com9387814568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026